10/30/2025 12:30
2025 Ecolab Watermark™ Study Reveals Hidden Impact of Artificial Intelligence

Ecolab, a global sustainability leader offering water solutions and services, today announced findings from its third annual Ecolab Watermark™ Study, which reports on water stewardship around the world. This year’s research highlights water’s connection to timely global trends, including new business opportunities from the rapid growth of artificial intelligence (AI) and consumer concern about its impact on vital natural resources. According to the Watermark Study, a majority of consumers acr...

10/30/2025 12:30
Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, today announced that its Suzhou, China laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification. This achievement marks the company’s second CLIA certification in 2025, following its San Diego facility earlier this year, underscoring Crown Bioscience’s continued commitment to expanding its global networ...

10/30/2025 12:45
Owlet® Strengthens Market Leadership as Dream Sight™ Becomes the First Baby Monitor Awarded the SGS Cybersecurity Mark

Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced that its newest video monitoring device, Dream Sight, is the first and only baby monitor to earn an SGS Cybersecurity Mark, a global certification that recognizes the highest standards in international cybersecurity and privacy. Dream Sight was tested by Brightsight, an SGS company and global leader in cybersecurity evaluations. For parents, this independent recognition provides extra re...

10/30/2025 13:00
Debiopharm Forges AI-powered Alliance With NetTargets to Pioneer Dual-payload ADCs Against Drug-resistant Cancers

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company dedicated to developing innovative therapies that respond to high unmet medical needs, today announced a strategic research collaboration with NetTargets (www.net-targets.com), a South Korean biotech company specializing in AI-enhanced systems biology for drug discovery, to rationally design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-generation Antibody-Drug Co...

10/30/2025 13:00
Bending Spoons Raises $710M for Continued Investment and Growth

Bending Spoons, one of Europe’s leading technology companies, today announced it has raised $710 million in equity at a pre-money valuation of $11 billion. The round was led by accounts advised by T. Rowe Price Investment Management, Inc., with participation from Baillie Gifford, Cox Enterprises, Durable Capital Partners, Fidelity Management & Research Company, Foxhaven Asset Management, and Radcliff, among others. Goldman Sachs International acted as sole placement agent and Clifford Chanc...

10/30/2025 13:30
Andersen Consulting Enhances Its Platform Through Collaboration With threon

Andersen Consulting deepens its business transformation and digital transformation capabilities through a Collaboration Agreement with threon, a Belgium-based consultancy known for delivering pragmatic, end-to-end strategy execution support. For more than 20 years, threon has been a trusted advisor for organizations looking to turn big ideas into delivering true business impact. The firm brings together their expertise in strategic portfolio management, digital transformation, and executive t...

10/30/2025 13:56
Staloral® Birch Phase III Study Successfully Meets Primary Endpoint, Demonstrating Efficacy in Children and Adolescents

Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of Staloral® Birch in children and adolescents with birch pollen-induced allergic rhino-conjunctivitis (ARC), with or without asthma, has successfully achieved its primary endpoint. The trial enrolled 553 children aged 5 -17 years with moderate to severe birch pollen-induced ARC, with or without as...

11/19/2025 17:15
Luma AI Raises $900 Million Series C Led by HUMAIN And Partners on 2 Gigawatt AI Supercluster in Saudi Arabia

Luma AI, the frontier artificial intelligence company building multimodal AGI, today announced it has raised $900 million in Series C funding, led by HUMAIN, a PIF company delivering global full-stack AI solutions, with significant participation from AMD Ventures, and existing investors Andreessen Horowitz, Amplify Partners, and Matrix Partners. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251119678010/en/(L–R) Amit Jain, CEO of L...

09/29/2025 12:00
New Esri Book Explores How Tactile Maps Provide Essential Context for People Who Are Visually Impaired

Esri, the global leader in location intelligence, has published Tactile Mapping: Cartography for People with Visual Impairments, a collection of expert-written chapters, case studies, and user stories demonstrating cartography for greater accessibility by people who are visually impaired. Tactile maps offer greater independence and inclusion for people who are blind, yet much of the research done in this area has remained inaccessible to a broader audience. Tactile Mapping: Cartography for Pe...